The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon

AIDS Research and Therapy

Volumn 3, Issue 1, 2006, Pages

  Ngondi, Judith L ^a   Oben, Julius ^a   Forkah, David Musoro ^a   Etame, Lucein Honore ^a   Mbanya, Dora ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ASCORBIC ACID; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; EFAVIRENZ; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL GROUP;

ADULT; ARTICLE; CAMEROON; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

EID: 33748752873     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-3-19     Document Type: Article

References (24)

1. WHO: Scaling up antiviral therapy in resource-limired settings: treatment guidelines for a public health approach revision. Geneva: world Health Organization 2003.
2. Zoccali C, Mallamaci F, Tripepi G: AGE's and carbonyl stress: potential pathogenic factors of long-term ureamic complications. Nephrol Dial Transplant 2000, 15(suppl 2):S7-10.
3. Halliwell B: Reactive oxygen species in living systems: source, Biochemistry and role in human disease. American Journal of Medicine 1991:S114-122.
4. Gornal AG, Bardwill CJ, David MM: Determination of serum proteins by means of the Biuret. J Bio Chem 1975, 177:751.
5. Okhawa H, Ohishi N, Yagi K: Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Annals Biochemistry 1979, 95:351-358.
6. Levine RL, Garland D, Oliver CN: The determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 1990, 186:464-477.
7. Pinnell AE, Northam BE: Quantitative in vitro determination of albumin in serum and plasma. Clin Chem 1978, 24:80.
8. Brown RK, Kelly FG: Evidence for increased oxidative damage in patients with cystic fibrosis. Paediatric Research 1994, 36:487-493.
9. Roe JH, Kuether CA: The determination of ascorbic acid, in whole blood and urine through the 2,4-dinitrophenylhydrazine derivative of dehydroascorbic acid. Journal of Biological Chemistry 1943, 147:399-407.
10. Thomas JA, Poland B, Honzatko R: Protein sulfydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys 1995, 319:1-9.
11. Laurent C, Kouanfack C, Koulla-Shiro S, Nkoue N, Bourgeois A, Calmy A, et al.: Effectiveness and safety of a generic fixed-dose combination of nevirapin, stavudin and Lamivudin in HIV-infected adults in Cameroon: open-label multicentre trial. Lancet 2004, 364(9428):29-34.
12. Allard JP, Aghdassi E, Chau J, Tam C, Kovacs CM, Salit IE, Wallmsley SL: Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. AIDS 1998, 12:1653-1659.
13. Papadopulos-Eleopulos E, Hedland-Thomas B, Causer D, et al.: Changes in thiols and glutamate as consequences of simian immunodeficiency virus infection. Lancet 1991, 11:1013.
14. Eck HP, Gmunder H, Hartmann M, et al.: Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe-Selyer 1989, 370:101-108.
15. Maytin M, Leopold J, Loscalzo J: Oxidant stress in the vasculature. Curr Atheroscler Rep 1999, 1:156-164.
16. Sen SK: Cellular thiols and redox-regulated signal transduction. Curr Top Cell Regul 2000, 36:1-30.
17. Hayes JD, McLellan LI: Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999, 31:273-300.
18. Emerit I, Serejo F, Filipe P, Alooui Youssefi, Fernandes A, Costa A, Freitas J, Ramalho F, Baptista A, de Moura MC: Clastogenic factors as biomarkers of oxidative stress in chronic hepatitis C. Digestion 2000, 62:1135-1138.
19. Miyata T, Sugiyama S, Saito A, Kurokawa K: Reactive carbonyl compounds related to uremic toxicity ("carbonyl stress"). Kidney Int 2001, 59(suppl 78):S25-31.
20. Beisel WR: Nutrition and immune function. J Nutr 1996, 126:2611S-2615S.
21. Wanke CA, Silva M, Knox TA, et al.: Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. CID 2000, 31:803-805.
22. HIV Lipodystrophy Case Definition Study: An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003, 361:726-735.
23. Oberley LW: Free radicals and diabetes. Free Radic Biol Med 1988, 5:113-124.
24. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the FraminghamStudy. Arterioscler Thromb Vasc Biol 2003, 23:434-439.